Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316)
Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytolo...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Guo, X. Mona [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes - Gibson, Diane M. ELSEVIER, 2017, an international journal : official publication of the Society of Gynecologic Oncologists [u.a.], Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:166 ; year:2022 ; pages:165 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0090-8258(22)01539-6 |
|---|
| Katalog-ID: |
ELV058852719 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV058852719 | ||
| 003 | DE-627 | ||
| 005 | 20230625011047.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221103s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0090-8258(22)01539-6 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica |
| 035 | |a (DE-627)ELV058852719 | ||
| 035 | |a (ELSEVIER)S0090-8258(22)01539-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.11 |2 bkl | ||
| 100 | 1 | |a Guo, X. Mona |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| 264 | 1 | |c 2022 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). | ||
| 700 | 1 | |a Chen, Ling |4 oth | |
| 700 | 1 | |a Klar, Maximilian |4 oth | |
| 700 | 1 | |a Roman, Lynda |4 oth | |
| 700 | 1 | |a Wright, Jason |4 oth | |
| 700 | 1 | |a Matsuo, Koji |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Gibson, Diane M. ELSEVIER |t Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |d 2017 |d an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] |g Orlando, Fla |w (DE-627)ELV000708127 |
| 773 | 1 | 8 | |g volume:166 |g year:2022 |g pages:165 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0090-8258(22)01539-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.11 |j Präventivmedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 166 |j 2022 |h 165 |y 166.2022, S165- | ||
| author_variant |
x m g xm xmg |
|---|---|
| matchkey_str |
guoxmonachenlingklarmaximilianromanlynda:2022----:omnlhrpceohrpoosrainoerytglwrdedmtilacrihainnprtnact |
| hierarchy_sort_str |
2022 |
| bklnumber |
44.11 |
| publishDate |
2022 |
| allfields |
10.1016/S0090-8258(22)01539-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica (DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Guo, X. Mona verfasserin aut Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). Chen, Ling oth Klar, Maximilian oth Roman, Lynda oth Wright, Jason oth Matsuo, Koji oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:166 year:2022 pages:165 https://doi.org/10.1016/S0090-8258(22)01539-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 166 2022 165 166.2022, S165- |
| spelling |
10.1016/S0090-8258(22)01539-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica (DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Guo, X. Mona verfasserin aut Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). Chen, Ling oth Klar, Maximilian oth Roman, Lynda oth Wright, Jason oth Matsuo, Koji oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:166 year:2022 pages:165 https://doi.org/10.1016/S0090-8258(22)01539-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 166 2022 165 166.2022, S165- |
| allfields_unstemmed |
10.1016/S0090-8258(22)01539-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica (DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Guo, X. Mona verfasserin aut Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). Chen, Ling oth Klar, Maximilian oth Roman, Lynda oth Wright, Jason oth Matsuo, Koji oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:166 year:2022 pages:165 https://doi.org/10.1016/S0090-8258(22)01539-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 166 2022 165 166.2022, S165- |
| allfieldsGer |
10.1016/S0090-8258(22)01539-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica (DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Guo, X. Mona verfasserin aut Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). Chen, Ling oth Klar, Maximilian oth Roman, Lynda oth Wright, Jason oth Matsuo, Koji oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:166 year:2022 pages:165 https://doi.org/10.1016/S0090-8258(22)01539-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 166 2022 165 166.2022, S165- |
| allfieldsSound |
10.1016/S0090-8258(22)01539-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica (DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Guo, X. Mona verfasserin aut Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). Chen, Ling oth Klar, Maximilian oth Roman, Lynda oth Wright, Jason oth Matsuo, Koji oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:166 year:2022 pages:165 https://doi.org/10.1016/S0090-8258(22)01539-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 166 2022 165 166.2022, S165- |
| source |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:166 year:2022 pages:165 |
| sourceStr |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:166 year:2022 pages:165 |
| format_phy_str_mv |
Article |
| bklname |
Präventivmedizin |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| authorswithroles_txt_mv |
Guo, X. Mona @@aut@@ Chen, Ling @@oth@@ Klar, Maximilian @@oth@@ Roman, Lynda @@oth@@ Wright, Jason @@oth@@ Matsuo, Koji @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000708127 |
| dewey-sort |
3610 |
| id |
ELV058852719 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058852719</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625011047.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221103s2022 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0090-8258(22)01539-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058852719</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(22)01539-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guo, X. Mona</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC).</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Ling</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klar, Maximilian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roman, Lynda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wright, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matsuo, Koji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:166</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:165</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0090-8258(22)01539-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">166</subfield><subfield code="j">2022</subfield><subfield code="h">165</subfield><subfield code="y">166.2022, S165-</subfield></datafield></record></collection>
|
| author |
Guo, X. Mona |
| spellingShingle |
Guo, X. Mona ddc 610 bkl 44.11 Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| authorStr |
Guo, X. Mona |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000708127 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.11 bkl Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| topic |
ddc 610 bkl 44.11 |
| topic_unstemmed |
ddc 610 bkl 44.11 |
| topic_browse |
ddc 610 bkl 44.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l c lc m k mk l r lr j w jw k m km |
| hierarchy_parent_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| hierarchy_parent_id |
ELV000708127 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000708127 |
| title |
Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| ctrlnum |
(DE-627)ELV058852719 (ELSEVIER)S0090-8258(22)01539-6 |
| title_full |
Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| author_sort |
Guo, X. Mona |
| journal |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| journalStr |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
165 |
| author_browse |
Guo, X. Mona |
| container_volume |
166 |
| class |
610 VZ 44.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Guo, X. Mona |
| doi_str_mv |
10.1016/S0090-8258(22)01539-6 |
| dewey-full |
610 |
| title_sort |
hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: a comparative effectiveness study (316) |
| title_auth |
Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| abstract |
Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). |
| abstractGer |
Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). |
| abstract_unstemmed |
Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC). |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316) |
| url |
https://doi.org/10.1016/S0090-8258(22)01539-6 |
| remote_bool |
true |
| author2 |
Chen, Ling Klar, Maximilian Roman, Lynda Wright, Jason Matsuo, Koji |
| author2Str |
Chen, Ling Klar, Maximilian Roman, Lynda Wright, Jason Matsuo, Koji |
| ppnlink |
ELV000708127 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/S0090-8258(22)01539-6 |
| up_date |
2024-07-06T20:15:32.556Z |
| _version_ |
1803862076351840256 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058852719</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625011047.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221103s2022 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0090-8258(22)01539-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001893.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058852719</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(22)01539-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guo, X. Mona</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hormonal therapy, chemotherapy, or observation for early- stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study (316)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives: Since 2009, peritoneal cytology is no longer required for FIGO surgical staging of endometrial cancer. However, guidelines continue to recommend its collection for assistance with postoperative risk stratification, despite not providing treatment guidelines in the case of positive cytology. We thus sought to examine trends, characteristics, and outcomes related to hormonal therapy (HT) or chemotherapy (CT) use for early-stage, low-grade endometrial cancer with malignant peritoneal cytology (MPC).</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Ling</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klar, Maximilian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roman, Lynda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wright, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matsuo, Koji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:166</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:165</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0090-8258(22)01539-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">166</subfield><subfield code="j">2022</subfield><subfield code="h">165</subfield><subfield code="y">166.2022, S165-</subfield></datafield></record></collection>
|
| score |
7.400278 |